Stillwater, OK, United States of America

George Edward Burrows

This inventor holds 2 USPTO granted patents. Top assignee: Oklahoma State University. Active years: 1995-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Edward Burrows. Retrieved from https://idiyas.com/inventor/george-edward-burrows

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1995-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of George Edward Burrows

Introduction

George Edward Burrows is a notable inventor based in Stillwater, OK (US). He has made significant contributions to the field of antiarrhythmic agents, holding a total of 2 patents. His work focuses on the development of novel compounds that have the potential to impact medical treatments.

Latest Patents

Burrows' latest patents include N-alkyl and N-acyl derivatives of 3,7-Diazabicyclo-[3.3.1]nonanes. These compounds are disclosed as multiclass antiarrhythmic agents. The general formula for these derivatives includes specific configurations where Q=S, Z=CH₂, and Y represents an N-acyl or N-alkyl group. This innovative approach aims to enhance the efficacy of antiarrhythmic treatments.

Career Highlights

George Edward Burrows is affiliated with Oklahoma State University, where he continues to engage in research and development. His academic background and ongoing projects contribute to the advancement of pharmaceutical sciences.

Collaborations

Some of his notable coworkers include Kenneth D Berlin and Gregory Lynn Garrison. Their collaborative efforts in research have further enriched the field of antiarrhythmic agents.

Conclusion

George Edward Burrows exemplifies the spirit of innovation in the medical field through his patents and research at Oklahoma State University. His work on antiarrhythmic agents showcases the importance of collaboration and dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…